SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025724
Filing Date
2024-07-01
Accepted
2024-07-01 08:00:24
Documents
18
Period of Report
2024-06-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 66012
2 ex4-1.htm EX-4 138962
3 ex4-2.htm EX-4.2 139366
4 ex10-1.htm EX-10.1 63820
5 ex99-1.htm EX-99.1 13836
  Complete submission text file 0001493152-24-025724.txt   724369

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cing-20240628.xsd EX-101.SCH 3781
7 XBRL DEFINITION FILE cing-20240628_def.xml EX-101.DEF 26635
8 XBRL LABEL FILE cing-20240628_lab.xml EX-101.LAB 36718
9 XBRL PRESENTATION FILE cing-20240628_pre.xml EX-101.PRE 25259
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5763
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40874 | Film No.: 241088213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)